'Secrets' of successful hospitals revealed

September 28, 2005

(BETHESDA, MD) - An in-depth look at hospitals that reduced treatment delays highlights steps other hospitals could take to provide rapid angioplasty treatment to heart attack patients, according to a new study in the Oct. 4, 2005, issue of the Journal of the American College of Cardiology.

"Time-to-treatment is important. The effectiveness of angioplasty in the treatment of heart attacks is highly dependent on the timeliness of therapy. There are some hospitals that are achieving great performance; and if you break down their approach, you can see many key strategies that can be applied more broadly, so perhaps best practice can become typical practice," said Harlan M. Krumholz, M.D., S.M., F.A.C.C. from the Yale University School of Medicine in New Haven, Connecticut.

American College of Cardiology and American Heart Association treatment guidelines say hospitals equipped to perform emergency angioplasty procedures should try to reopen blocked blood vessels of heart attack patients within 90 minutes of a patient's arrival. The study authors produced a flow chart that outlines the steps successful hospitals took to meet that "door-to-balloon" time standard. Key steps include: The researchers also said that the hospital staffs accepted the fact that there were occasional "false starts" in which angioplasty teams would get ready and then be told to stand down. The events were seen as a reasonable tradeoff for dramatically trimming door-to-balloon times and reducing heart muscle damage in those patients who were indeed having heart attacks.

The researchers used a national registry of heart attack treatment performance to identify hospitals that met the 90-minute door-to-balloon angioplasty treatment standard. Then they did indepth onsite interviews with staff at 11 hospitals that had achieved the greatest reductions in treatment times over a four-year period.

The authors said that effective collaboration between ambulance crews, emergency medicine staff and angioplasty teams could trim door-to-balloon times to 60 minutes or less.

"Not all hospitals may be able to replicate this idealized flowchart; but we believe that there will be useful and practical value for all hospitals," Dr. Krumholz said.

"This approach also helps us see what has worked in the real world, not just what might be designed as ideal interventions and implemented in a controlled study, so it gives us some faith that the efforts are feasible; not easy, but achievable," added lead author Elizabeth H. Bradley, Ph.D., also from the Yale University School of Medicine.

The researchers also had advice for patients who suspect they may be having a heart attack: call 9-1-1, instead of driving to a hospital.

"The value of activating 911 is not that an ambulance will drive faster than a family member taking you in the car, but rather that medical assessment and treatments can begin earlier, en route to the hospital," Dr. Bradley said.

Dr. Krumholz said the practices they identified do not necessarily cost more.

"Most of the innovations in the flowchart are about working smarter, not necessarily harder or with more staff. It is about proper organization and flow. It is about planning and preparing and communicating to everyone what is expected and when," Dr. Krumholz said.

"Real improvement in such a complex treatment process involves collaboration and coordination of many departments and disciplines, in ways more simple clinical processes may not require. This is bringing a systems mentality to medicine, whereby exceptional performance is not a property of individual clinicians but a property of more ideally designed systems in which individuals work," Dr. Bradley added.

However, Dr. Krumholz noted that many ambulance crews do not have the equipment or training to perform ECGs in the field. He said this study shows investing in pre-hospital ECG capabilities would improve performance.

Christopher B. Granger, M.D., F.A.C.C., from the Duke University Medical Center, who was not connected with this study, said that it provides important new information. While clinical trials show what things should be done, and clinical practice registries reveal gaps between that ideal practice and what's actually happening in hospitals, this study addresses the critical practical issue of how practice can be improved.

"We don't have much information on how we can improve; and this study begins to bridge that gap by systematically describing what aspects of the approach hospitals take seems to be related to better performance," Dr. Granger said.

W. Douglas Weaver, M.D. from the Henry Ford Heart & Vascular Institute in Detroit, Michigan, who also was not part of this research team, said the study affirms what was known about how to reduce treatment times.

"It takes teamwork to achieve the best results, a collaboration between emergency services, paramedics and cardiologists and catheterization lab personnel. I'd also say that the value of a pre-hospital ECG is that 'a picture is worth a thousand words.' When medics and doctors see diagnostic ST segment elevation; they become focused on the problem and things happen quickly," Dr. Weaver said.
-end-
Disclosure Box
Sources quoted in this news release do not report any potential conflicts of interest regarding this topic.

This research was supported by the National Heart, Lung, and Blood Institute (NHLBI), under grant #R01HL072575. Dr. Bradley is supported by the Patrick and Catherine Weldon Donaghue Medical Research Foundation (# 02-102) and a grant from the Claude D. Pepper Older Americans Independence Center at Yale (#P30AG21342).

American College of Cardiology

Related Angioplasty Articles from Brightsurf:

Ticagrelor was not superior to clopidogrel to reduce heart attack risk during angioplasty
A new study found the rate of heart attack and severe complications before, during or soon after elective surgery to open a blocked artery was similar between patients treated with clopidogrel and those who received the more potent antiplatelet medication ticagrelor.

Study finds significant variability in doctors' angioplasty death rates
Some doctors have higher or lower than expected death rates from coronary angioplasty procedures, also known as percutaneous coronary intervention (PCI); however, doctors should not be judged solely on the rate of patients who die from the procedure.

Beta-blockers following angioplasty show little benefit for some older patients
Following coronary angioplasty, beta-blockers did not significantly improve mortality rates or reduce the number of future cardiovascular incidents for older patients with stable angina but no history of heart attack or heart failure, according to a study published today in the JACC: Cardiovascular Interventions.

Sleep disorders may predict heart events after angioplasty
People who have had procedures to open blocked heart arteries after acute coronary syndrome (ACS) may have a higher risk of death, heart failure, heart attack and stroke if they have sleep disorders, such as sleep apnea, compared to those who don't.

Reasons for hospital-level variations in bleeding post-angioplasty are unclear
The use of bleeding avoidance strategies has only a modest effect on the variation in bleeding rates post-angioplasty among hospitals performing this procedure, leaving about 70 percent of the causes for this variation unexplained, according to a study published today in JACC: Cardiovascular Interventions.

US prediction models for kidney injury following angioplasty hold up in Japan
Models developed by the American College of Cardiology NCDR CathPCI Registry to predict the likelihood of angioplasty patients developing acute kidney injury and acute kidney injury requiring dialysis have proven to be effective among patients in Japan.

IV beta blockers before angioplasty are safe, but offer no clinical benefit
Giving intravenous beta blockers before performing a coronary angioplasty in patients who had experienced the deadliest form of heart attack -- ST-segment elevation myocardial infarction (STEMI) -- was safe but did not reduce heart attack severity or improve blood flow from the heart's main pumping chamber, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.

Life-threatening bowel ischemia can often be treated by balloon angioplasty
Acute mesenteric ischemia (AMI) can be successfully treated with endovascular therapy such as balloon angioplasty, according to research from the University of Eastern Finland.

Radial access used less than femoral approach for emergency angioplasty
Although using the radial artery as the access point for angioplasty has been linked to reduced bleeding compared to use of the femoral artery, only a small number of high-risk heart attack patients who undergo rescue angioplasty -- emergency procedures following failed therapy with clot-busting drugs -- are treated by radial access, according to a study published today in the Journal of the American College of Cardiology: Cardiovascular Interventions.

Use of rarely appropriate angioplasty procedures declined sharply
The number of angioplasty procedures classified as rarely appropriate declined sharply between 2010 and 2014, as did the number of those performed on patients with non-acute conditions, according to a study published today in the Journal of the American Medical Association and simultaneously presented at a meeting of the American Heart Association in Orlando.

Read More: Angioplasty News and Angioplasty Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.